Oncodaily·4 min read·hard
PSMA PET/CT Guidance Linked to Longer Biochemical Control in Oligometastatic Castration
N
Nare Hovhannisyan
✦AI Summary
A study of 102 patients suggests that using PSMA PET/CT imaging to guide metastasis-directed therapy may improve survival outcomes in castration-resistant prostate cancer. Researchers noted that while promising, the retrospective nature of the study prevents establishing a direct causal link.
An updated analysis of the PRECISE-MDT cohort has found that metastasis-directed therapy guided by prostate-specific membrane antigen PET/CT was associated with longer biochemical recurrence–free survival and improved overall survival in patients with oligometastatic castration-resistant prostate cancer.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in